A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma.

by | Aug 1, 2025 | Clinical Trials | 0 comments

​ Conditions: Advanced Melanoma

Interventions: Drug: LBL-024 for Injection; Drug: LBL-007 Injection; Drug: Toripalimab Injection

Sponsors: Nanjing Leads Biolabs Co.,Ltd

Not yet recruiting Conditions: Advanced Melanoma
Interventions: Drug: LBL-024 for Injection; Drug: LBL-007 Injection; Drug: Toripalimab Injection
Sponsors: Nanjing Leads Biolabs Co.,Ltd
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *